ODIWIN-R KIT
MRP: 405
Packaging: 20 KIT
Pack Type: injection
Composition:
Combipack of Ondansetron 2mg. & Ranitidine 25mg
Indication:
Nausea & Vomiting associated with - Radiotherapy - Chemotherapy Prophylaxis & Treatment of Post Operative Nausea & Vomiting
Description:
This combipack injection combines two essential medicines:
Ondansetron 2 mg/ml – a 5-HT3 receptor antagonist that effectively controls nausea and vomiting associated with chemotherapy, radiotherapy, and surgery.
Ranitidine 25 mg/ml – a histamine H2-receptor antagonist that reduces stomach acid production, preventing acid reflux, gastritis, and stress ulcers.
Together, this combination is highly effective in:
Preventing post-operative nausea and vomiting (PONV)
Managing chemotherapy/radiation-induced nausea and gastric discomfort
Preventing gastric irritation due to NSAIDs or stress in hospitalized patients
Used in pre-anesthesia protocols
Each unit typically includes two ampoules or a dual-chamber vial, one for each drug, to be administered separately as per instructions.
Tags:
- Dual action: Controls both vomiting and gastric acid secretion
- Effective pre-op and post-op medication
- Reduces chances of gastric complications from anesthesia or chemotherapy
- Easy-to-administer separate ampoules or vials
- Suitable for hospital, oncology, and surgical care settings
Usage Information
Dosage
Route: Intravenous (IV) administration, separately Ondansetron: 2 mg slowly IV before chemo/surgery Ranitidine: 25 mg IV diluted in saline over 5 minutes To be administered by a medical professional Frequency as per medical indication (usually every 8–12 hours if required)
Side Effects
Ondansetron: Headache, constipation, dizziness, rare QT prolongation Ranitidine: Mild headache, fatigue, rarely bradycardia or elevated liver enzymes Local injection site irritation (rare)
Contraindications
Hypersensitivity to either Ondansetron or Ranitidine Congenital long QT syndrome (Ondansetron) Severe hepatic impairment Use with caution in patients with renal dysfunction (Ranitidine) Concomitant use of QT-prolonging drugs
Availability
Ondansetron and Ranitidine combipack injection Antiemetic and antacid injection combo Preoperative nausea relief injection Post-chemotherapy gastric protection Dual action vomiting and acidity control Ranitidine 25mg + Ondansetron 2mg injection uses